SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: (R,E)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl) phenyl)prop-2-en-1-amine HCl ;
Synonym: Dehydro Cinacalcet Hydrochloride
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: C[C@@H](NC/C=C/C1=CC(C(F)(F)F)=CC=C1)C2=CC=CC3=CC=CC=C32.Cl
Cinacalcet Impurity C is chemically (R,E)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl) phenyl)prop-2-en-1-amine HCl ;. It is also known as Dehydro Cinacalcet Hydrochloride . Cinacalcet Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Cinacalcet Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cinacalcet.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development
Benedetta Pasquini a, Serena Orlandini a,∗, Mercedes Villar-Navarro b, Claudia Caprini a, Massimo Del Bubbaa, Michal Dousaˇ c, Alessandro Giuffrida d, Roberto Gotti e, Sandra Furlanetto
Journal of Chromatography A Volume 1568, 21 September 2018, Pages 205-213
Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Impurities in Cinacalcet Hydrochloride API and its Formulation
Pingili Sunil reddy, Thummala Veera Raghava Raju , Penmetsa Satyanarayana RAJU , Nadimpalli Sunil Varma 1 , Kondra Sudhakar BABU
Sci. Pharm. 2015, 83(4), 583-598